How Neurocrine Biosciences used altmetrics to measure success

<div>Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders.</div><div><br></div><div>For nearly three decades, Neurocrine Biosciences has specialized in FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis, uterine fibroids and clinical programs in multiple therapeutic areas.</div><div><br></div><div><div>Chirag Shah, Head of Publications Strategy and</div><div>Office of Grants/Education at Neurocrine Biosciences, spoke to us about how altmetrics were particularly helpful in the therapeutic area of tardive dyskinesia (TD)</div></div><div><br></div>